Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks
Public ClinicalTrials.gov record NCT01068600. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-week Treatment, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Once Daily Indacaterol in Patients With Chronic Obstructive Pulmonary Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This 12-week study evaluated the efficacy and safety of indacaterol versus placebo.
Study identification
- NCT ID
- NCT01068600
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 318 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2009
- Primary completion
- May 31, 2010
- Completion
- Not listed
- Last update posted
- Aug 18, 2011
Started 2010
United States locations
- U.S. sites
- 54
- U.S. states
- 22
- U.S. cities
- 49
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Anniston | Alabama | 36207-5710 | — |
| Novartis Investigative Site | Jasper | Alabama | 35501 | — |
| Novartis Investigator Site | Glendale | Arizona | 85306 | — |
| Novartis Investigator Site | Phoenix | Arizona | 85006 | — |
| Novartis Investigator Site | Fullerton | California | 92835 | — |
| Novartis Investigator Site | Los Angeles | California | 90048 | — |
| Novartis Investigator Site | Los Angeles | California | 90095 | — |
| Novartis Investigator Site | Riverside | California | 92506 | — |
| Novartis Investigative Site | Clearwater | Florida | 33756 | — |
| Novartis Investigative Site | Clearwater | Florida | 33765 | — |
| Novartis Investigative Site | Hollywood | Florida | 33021 | — |
| Novartis Investigative site | Miami | Florida | 33145 | — |
| Novartis Investigative Site | Tampa | Florida | 33603 | — |
| Novartis Investigative Site | Winter Park | Florida | 32789 | — |
| Novartis Investigative Site | Atlanta | Georgia | 30342 | — |
| Novartis Investigator Site | Normal | Illinois | 61761 | — |
| Novartis Investigator Site | Iowa City | Iowa | 52242 | — |
| Novartis Investigative Site | Madisonville | Kentucky | 42431 | — |
| Novartis Investigator Site | Baton Rouge | Louisiana | 70808 | — |
| Novartis Investigator Site | Opelousas | Louisiana | 70570 | — |
| Novartis Investigator Site | Saint Charles | Missouri | 63301 | — |
| Novartis Investigator Site | St Louis | Missouri | 63141 | — |
| Novartis Investigator Site | Lincoln | Nebraska | 68510 | — |
| Novartis Investigator Site | Omaha | Nebraska | 68114 | — |
| Novartis Investigator Site | Omaha | Nebraska | 68134 | — |
| Novartis Investigator Site | Henderson | Nevada | 89014 | — |
| Novartis Investigator Site | Las Vegas | Nevada | 89119 | — |
| Novartis Investigative Site | Cherry Hill | New Jersey | 08003 | — |
| Novartis Investigator Site | Albuquerque | New Mexico | 87108 | — |
| Novartis Investigative Site | Charlotte | North Carolina | 28207 | — |
| Novartis Investigative Site | Raleigh | North Carolina | 27607 | — |
| Novartis Investigative Site | Shelby | North Carolina | 28152 | — |
| Novartis Investigative Site | Canton | Ohio | 44718 | — |
| Novartis Investigator Site | Cincinnati | Ohio | 45242 | — |
| Novartis Investigative Site | Columbus | Ohio | 43213 | — |
| Novartis Investigative Site | Columbus | Ohio | 43215 | — |
| Novartis Investigator Site | Marion | Ohio | 43302 | — |
| Novartis Investigator Site | Eugene | Oregon | 97404 | — |
| Novartis Investigator Site | Medford | Oregon | 97504 | — |
| Novartis Investigative Site | Cumberland | Rhode Island | 02864 | — |
| Novartis Investigative Site | Pawtucket | Rhode Island | 02860 | — |
| Novartis Investigative Site | Charleston | South Carolina | 29407 | — |
| Novartis Investigative Site | Charleston | South Carolina | 29412 | — |
| Novartis Investigative Site | Easley | South Carolina | 29640 | — |
| Novartis Investigative site | Greenville | South Carolina | 29615 | — |
| Novartis Investigative Site | North Charleston | South Carolina | 29406 | — |
| Novartis Investigative Site | Spartanburg | South Carolina | 29303 | — |
| Novartis Investigative Site | Union | South Carolina | 29379 | — |
| Novartis Investigator Site | Arlington | Texas | 76012 | — |
| Novartis Investigator Site | Dickinson | Texas | 77539 | — |
| Novartis Investigator Site | El Paso | Texas | 79903 | — |
| Novartis Investigator Site | McKinney | Texas | 75069 | — |
| Novartis Investigative Site | South Burlington | Vermont | 05403 | — |
| Novartis Investigative Site | Richmond | Virginia | 23229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01068600, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2011 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01068600 live on ClinicalTrials.gov.